Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Curr Opin Obstet Gynecol. 2017 Aug;29(4):195–201. doi: 10.1097/GCO.0000000000000370

Table 1.

Key Points

  • Data on the association between use of fertility medications and cancer are limited and come principally from observational cohort and case-control studies with several methodological issues.

  • While infertility per se is a risk factor for a number of female cancers including breast, endometrial and invasive ovarian cancer, there are insufficient data to suggest a meaningful association between fertility medication use and these cancers.

  • Several studies have suggested a small increased risk of developing borderline ovarian cancer; however, the absolute increased risk is small and these indolent tumors have a favorable prognosis.

  • There is insufficient evidence to suggest an association between fertility medication use and cancers of the cervix, thyroid and colon or melanoma.

  • Additional studies with longer follow-up are needed to determine whether unique subgroups of women are at increased risk of developing cancer following fertility treatment.